These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

716 related items for PubMed ID: 18203048

  • 1. Amisulpride augmentation in patients with schizophrenia partially responsive or unresponsive to clozapine. A randomized, double-blind, placebo-controlled trial.
    Assion HJ, Reinbold H, Lemanski S, Basilowski M, Juckel G.
    Pharmacopsychiatry; 2008 Jan; 41(1):24-8. PubMed ID: 18203048
    [Abstract] [Full Text] [Related]

  • 2. Amisulpride augmentation of clozapine: an open non-randomized study in patients with schizophrenia partially responsive to clozapine.
    Munro J, Matthiasson P, Osborne S, Travis M, Purcell S, Cobb AM, Launer M, Beer MD, Kerwin R.
    Acta Psychiatr Scand; 2004 Oct; 110(4):292-8. PubMed ID: 15352931
    [Abstract] [Full Text] [Related]

  • 3. Improvement of negative and positive symptoms in treatment-refractory schizophrenia: a double-blind, randomized, placebo-controlled trial with memantine as add-on therapy to clozapine.
    de Lucena D, Fernandes BS, Berk M, Dodd S, Medeiros DW, Pedrini M, Kunz M, Gomes FA, Giglio LF, Lobato MI, Belmonte-de-Abreu PS, Gama CS.
    J Clin Psychiatry; 2009 Oct; 70(10):1416-23. PubMed ID: 19906345
    [Abstract] [Full Text] [Related]

  • 4. A double-blind study of combination of clozapine with risperidone in patients with schizophrenia: effects on cognition.
    Akdede BB, Anil Yağcioğlu AE, Alptekin K, Turgut TI, Tümüklü M, Yazici MK, Jayathilake K, Tunca Z, Göğüş A, Meltzer HY.
    J Clin Psychiatry; 2006 Dec; 67(12):1912-9. PubMed ID: 17194269
    [Abstract] [Full Text] [Related]

  • 5. Ziprasidone and amisulpride effectively treat negative symptoms of schizophrenia: results of a 12-week, double-blind study.
    Olié JP, Spina E, Murray S, Yang R.
    Int Clin Psychopharmacol; 2006 May; 21(3):143-51. PubMed ID: 16528136
    [Abstract] [Full Text] [Related]

  • 6. Amisulpride augmentation in clozapine-unresponsive schizophrenia (AMICUS): a double-blind, placebo-controlled, randomised trial of clinical effectiveness and cost-effectiveness.
    Barnes TR, Leeson VC, Paton C, Marston L, Davies L, Whittaker W, Osborn D, Kumar R, Keown P, Zafar R, Iqbal K, Singh V, Fridrich P, Fitzgerald Z, Bagalkote H, Haddad PM, Husni M, Amos T.
    Health Technol Assess; 2017 Sep; 21(49):1-56. PubMed ID: 28869006
    [Abstract] [Full Text] [Related]

  • 7. Amisulpride versus risperidone in the treatment of depression in patients with schizophrenia: a randomized, open-label, controlled trial.
    Kim SW, Shin IS, Kim JM, Lee SH, Lee JH, Yoon BH, Yang SJ, Hwang MY, Yoon JS.
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Oct 01; 31(7):1504-9. PubMed ID: 17692448
    [Abstract] [Full Text] [Related]

  • 8. Efficacy and tolerability of ziprasidone versus risperidone as augmentation in patients partially responsive to clozapine: a randomised controlled clinical trial.
    Zink M, Kuwilsky A, Krumm B, Dressing H.
    J Psychopharmacol; 2009 May 01; 23(3):305-14. PubMed ID: 18562423
    [Abstract] [Full Text] [Related]

  • 9. Combination of clozapine and amisulpride in treatment-resistant schizophrenia--case reports and review of the literature.
    Zink M, Knopf U, Henn FA, Thome J.
    Pharmacopsychiatry; 2004 Jan 01; 37(1):26-31. PubMed ID: 14750045
    [Abstract] [Full Text] [Related]

  • 10. Which role for amisulpride in rehabilitation of schizophrenic patients with acute exacerbation?
    Blin O.
    Encephale; 2000 Oct 01; 26 Spec No 1():7-11. PubMed ID: 11294060
    [Abstract] [Full Text] [Related]

  • 11. Donepezil augmentation of clozapine monotherapy in schizophrenia patients: a double blind cross-over study.
    Stryjer R, Strous R, Bar F, Shaked G, Shiloh R, Rozencwaig S, Grupper D, Buchman N, Kotler M, Rabey JM, Weizman A.
    Hum Psychopharmacol; 2004 Jul 01; 19(5):343-6. PubMed ID: 15252826
    [Abstract] [Full Text] [Related]

  • 12. Augmentation of clozapine with a second antipsychotic--a meta-analysis of randomized, placebo-controlled studies.
    Taylor DM, Smith L.
    Acta Psychiatr Scand; 2009 Jun 01; 119(6):419-25. PubMed ID: 19245679
    [Abstract] [Full Text] [Related]

  • 13. Comparison of clozapine-amisulpride and clozapine-quetiapine combinations for patients with schizophrenia who are partially responsive to clozapine: a single-blind randomized study.
    Genç Y, Taner E, Candansayar S.
    Adv Ther; 2007 Jun 01; 24(1):1-13. PubMed ID: 17526456
    [Abstract] [Full Text] [Related]

  • 14. Amisulpride for the treatment of very-late-onset schizophrenia-like psychosis.
    Psarros C, Theleritis CG, Paparrigopoulos TJ, Politis AM, Papadimitriou GN.
    Int J Geriatr Psychiatry; 2009 May 01; 24(5):518-22. PubMed ID: 19072747
    [Abstract] [Full Text] [Related]

  • 15. Amisulpride: a review of its efficacy in schizophrenia.
    Möller HJ.
    Acta Psychiatr Scand Suppl; 2000 May 01; 400():17-22. PubMed ID: 10823307
    [Abstract] [Full Text] [Related]

  • 16. Amisulpride treatment of clozapine-induced hypersalivation in schizophrenia patients: a randomized, double-blind, placebo-controlled cross-over study.
    Kreinin A, Novitski D, Weizman A.
    Int Clin Psychopharmacol; 2006 Mar 01; 21(2):99-103. PubMed ID: 16421461
    [Abstract] [Full Text] [Related]

  • 17. Combined use of amisulpride and clozapine for patients with treatment-resistant schizophrenia.
    Cook B, Hoogenboom G.
    Australas Psychiatry; 2004 Mar 01; 12(1):74-6. PubMed ID: 15715745
    [Abstract] [Full Text] [Related]

  • 18. Nonresponse to clozapine and premorbid functioning in treatment of refractory schizophrenia.
    Kelly DL, Feldman S, Boggs DL, Gale E, Conley RR.
    Compr Psychiatry; 2010 Mar 01; 51(3):298-302. PubMed ID: 20399340
    [Abstract] [Full Text] [Related]

  • 19. Amisulpride versus moclobemide in treatment of clozapine-induced hypersalivation.
    Kreinin A, Miodownik C, Sokolik S, Shestakova D, Libov I, Bergman J, Lerner V.
    World J Biol Psychiatry; 2011 Dec 01; 12(8):620-6. PubMed ID: 20964499
    [Abstract] [Full Text] [Related]

  • 20. Clinical effects of a randomized switch of patients from clozaril to generic clozapine.
    Kluznik JC, Walbek NH, Farnsworth MG, Melstrom K.
    J Clin Psychiatry; 2001 Dec 01; 62 Suppl 5():14-7; discussion 23-4. PubMed ID: 11305843
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 36.